Skip to main content
. 2018 Oct 31;9(23):4510–4520. doi: 10.7150/jca.27611

Figure 2.

Figure 2

Forest plots of the overall analyses for comparison 1, comparing RT/CRT plus anti-EGFR mAbs and RT/CRT alone. (A) Overall survival; (B) disease-free survival; (C) locoregional recurrence-free survival; (D) distant metastasis-free survival. RT = radiotherapy; CRT = chemoradiotherapy; anti-EGFR mAbs = anti-epidermal growth factor receptor monoclonal antibodies.